Hagop Kantarjian

Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph+ ALL

Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X:

“A comprehensive review of the research history and current status of ponatinib in CML and Ph+ ALL
Elias Jabbour of MD Anderson Comprehensive Cancer Center.”

Source: Hagop Kantarjian/X

cancer cancer center research cancer therapy cancer treatment CML research comprehensive review current status Elias Jabbour Hagop Kantarjian leukemia professor Leukemia Research MD Anderson Cancer Center OncoDaily Oncology oncology update Ph- ALL ponatinib history ponatinib review